Body composition, defined as the proportions and distribution of lean and fat tissues in the
human body, is an emergent theme in clinical oncology. Severe muscle depletion …

Muscle wasting often occurs as a consequence of anticancer treatments and is indicative of
worse outcomes and poor quality of life in cancer patients. Accurate assessment of body …

Although higher body mass index (BMI) increases the incidence of many cancers, BMI can
also exhibit a null or U-shaped relationship with survival among patients with existing …

Skeletal muscle loss, commonly known as sarcopenia, is highly prevalent and prognostic of
adverse outcomes in oncology. However, there is limited information on adults with early …

As populations continue to age worldwide, the impact of sarcopenia on public health will
continue to grow. The clinically relevant and increasingly common diagnosis of sarcopenia …

Background Home parenteral nutrition (HPN) can improve survival, quality of life, nutritional
and functional status in cancer patients. Bioelectrical impedance analysis (BIA) is a non …

Background Both low skeletal muscle mass (LSMM) and delirium are frequently seen in
elderly patients. This study aimed to investigate the association between preoperative …

Background & aims Patients with chronic intestinal failure (CIF) are at risk of altered body
composition and impaired muscle function, which may negatively affect clinical outcome …

People receiving cancer treatment are at nutritional risk. Their eating problems can lead to
malnutrition and weight loss. Involuntary weight loss is also a defining characteristic of tumor …

Purpose To investigate the effect of body mass index (BMI) on survival in patients with breast
cancer according to tumor subtype, metabolic syndrome, and systemic treatment. Patients …